Christina Konstantaki

Statin treatment strategy and LDL cholesterol response associate with circulating Amyloid beta 1-40 in a prospective dyslipidemia cohort.

Background: Circulating amyloid beta 1-40 (Aβ40), a pro-inflammatory and pro-atherogenic peptide, is an emerging biomarker in atherosclerotic cardiovascular disease (ASCVD), but evidence on its modulation by cardiovascular therapies is limited and conflicting. We explored associa...